Growth Metrics

Verastem (VSTM) Revenue (2018 - 2026)

Verastem's quarterly Revenue came in at $18.7 million in Q1 2026, up 6.48% quarter-over-quarter from $17.5 million in Q4 2025.

Verastem has reported Revenue for 8 years, with the latest figure at $18.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Revenue changed N/A year-over-year to $18.7 million; the trailing twelve-month figure through Mar 2026 stood at $49.6 million (changed N/A YoY), and the FY2025 full-year result was $30.9 million, up 209.14% from the prior year.
  • Revenue for Q1 2026 stood at $18.7 million, up from $17.5 million in the prior quarter.
  • The five-year high for Revenue was $18.7 million in Q1 2026, with the low at $2.1 million in Q2 2025.
  • Average Revenue over 4 years is $10.4 million, with a median of $10.6 million recorded in 2024.
  • Year-over-year, Revenue surged 158.05% in 2022 and plunged 78.63% in 2025.
  • Tracing VSTM's Revenue over 4 years: stood at $2.6 million in 2022, then surged by 285.21% to $10.0 million in 2024, then jumped by 75.35% to $17.5 million in 2025, then rose by 6.48% to $18.7 million in 2026.
  • The last three Revenue figures came in at $18.7 million (Q1 2026), $17.5 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.17 Bn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn 18.67 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 18.67 Mn
Dec 31, 2025 17.54 Mn
Sep 30, 2025 11.24 Mn
Jun 30, 2025 2.14 Mn
Jun 30, 2024 10.00 Mn
Mar 31, 2022 2.60 Mn
Dec 31, 2021 545,000.00
Sep 30, 2021 2,000.00
Jun 30, 2021 500,000.00
Mar 31, 2021 1.01 Mn
Dec 31, 2020 506,000.00
Sep 30, 2020 78.65 Mn
Jun 30, 2020 4.31 Mn
Mar 31, 2020 5.06 Mn
Dec 31, 2019 3.62 Mn
Sep 30, 2019 9.03 Mn
Jun 30, 2019 3.14 Mn
Mar 31, 2019 1.67 Mn
Dec 31, 2018 1.21 Mn
Sep 30, 2018 15.51 Mn
Jun 30, 2018 10.00 Mn